Intestinal disorders in these affected individuals likely stem from GC-C/cGMP-enhanced ion movement and include inflammatory bowel disease (specifically Crohn’s disease), intestinal obstruction associated with volvulus, and infectious gastroenteritis. The gene discussed is GUCY2C; the disease is inflammatory bowel disease.